SCHEMBL7635018

SCHEMBL7635018

CC(NCc1ccco1)C(O)c1ccccc1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.55
NPSR1 Q6W5P4 3/20 0.55
LMNA P02545 2/20 0.55
MAPK1 P28482 2/20 0.55
HTT P42858 1/20 0.55
MAPT P10636 1/20 0.55
L3MBTL1 Q9Y468 1/20 0.55
CYP2D6 P10635 3/20 0.54
CYP2C19 P33261 3/20 0.54
CYP1A2 P05177 2/20 0.54
KDM4E B2RXH2 1/20 0.51
KMT2A Q03164 6/20 0.49
MEN1 O00255 4/20 0.49
CYP3A4 P08684 2/20 0.49
CYP2C9 P11712 2/20 0.49
CHRM2 P08172 1/20 0.49
ADRA1A P35348 1/20 0.49
RGS12 O14924 1/20 0.49
GLA P06280 1/20 0.49
PKM P14618 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9729341 0.84 L3MBTL1 (0.57) ALDH1A1NPSR1LMNAMAPTL3MBTL1
SCHEMBL8795665 0.82 ALDH1A1 (0.49) ALDH1A1MAPTL3MBTL1KDM4EKMT2A
SCHEMBL28318922 0.79 L3MBTL1 (0.66) ALDH1A1NPSR1LMNAMAPK1MAPT
SCHEMBL7637484 0.77 LMNA (0.79) ALDH1A1NPSR1LMNAMAPK1HTT
SCHEMBL5270097 0.77 LMNA (0.79) ALDH1A1NPSR1LMNAMAPK1HTT
SCHEMBL7785516 0.77 LMNA (0.79) ALDH1A1NPSR1LMNAMAPK1HTT
SCHEMBL9462452 0.75 MAPT (0.70) ALDH1A1NPSR1LMNAMAPTL3MBTL1
SCHEMBL9462454 0.75 MAPT (0.70) ALDH1A1NPSR1LMNAMAPTL3MBTL1
SCHEMBL105281 0.75 MAPT (0.51) ALDH1A1MAPTL3MBTL1CYP2D6CYP2C19
SCHEMBL25455699 0.73 CYP2D6 (0.62) ALDH1A1NPSR1LMNAMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20020193347-A1 Using an optically active N-substituted chiral derivative of norephedrine as ligand for enantioselective reduction of unsaturated compounds carrying functional groups by a hydrogen transfer method PPG-SIPSY, A CORPORATION OF FRANCE (FR) 2002-12-19 US claimed
US-20020193347-A1 Using an optically active N-substituted chiral derivative of norephedrine as ligand for enantioselective reduction of unsaturated compounds carrying functional groups by a hydrogen transfer method PPG-SIPSY, A CORPORATION OF FRANCE (FR) 2002-12-19 US disclosed